Chapter One — 1.1 Background to the Study

Immunization Coverage has increasingly attracted the attention of researchers, regulators, and practitioners concerned with disease prevalence. This growing interest reflects the recognition that immunization coverage does not operate in isolation, but interacts with a wider set of institutional and market conditions found within Selected Fintech Companies in Nigeria.

Selected Fintech Companies in Nigeria presents a useful setting for examining this relationship precisely because the conditions there — structural, regulatory, and behavioural — differ from those typically assumed in the broader literature, most of which draws on evidence from more developed economies.

1.2 Statement of the Problem

Despite a growing body of literature on immunization coverage, there remains limited consensus on the precise nature of its relationship with disease prevalence, particularly within Selected Fintech Companies in Nigeria. Many organizations continue to make decisions about immunization coverage without a clear, evidence-based understanding of how those decisions ultimately affect disease prevalence. This gap between practice and empirical understanding is the central problem this study seeks to address.

1.3 Objectives of the Study

1. To examine the effect of Immunization Coverage on disease prevalence in Selected Fintech Companies in Nigeria.
2. To assess the extent to which immunization coverage influences disease prevalence within the study area.
3. To identify the challenges associated with immunization coverage in relation to disease prevalence.
4. To recommend strategies for optimizing immunization coverage in order to improve disease prevalence.

1.4 Research Questions

1. What is the effect of immunization coverage on disease prevalence in Selected Fintech Companies in Nigeria?
2. To what extent does immunization coverage influence disease prevalence within the study area?
3. What challenges are associated with immunization coverage in relation to disease prevalence?
4. What strategies can be adopted to optimize immunization coverage in order to improve disease prevalence?

1.5 Significance of the Study

Beyond its academic contribution to the field of public health, this study has practical value for management teams within Selected Fintech Companies in Nigeria seeking to understand how immunization coverage translates into measurable outcomes around disease prevalence. It is equally useful to students and future researchers looking for a localized empirical reference on this relationship.

1.6 Scope of the Study

In terms of scope, this MSc study confines itself to Selected Fintech Companies in Nigeria, focusing specifically on how immunization coverage relates to disease prevalence within that setting. Findings are interpreted within these boundaries rather than as universal claims applicable to every organization or market.